We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management

By LabMedica International staff writers
Posted on 17 Dec 2024

Millions of individuals with diabetes monitor their glucose levels daily using finger-stick devices that draw and analyze blood. More...

But imagine if this could be done with just a sweat sensor. This is the concept behind new research that could change diabetes management by eliminating the discomfort and inconvenience of traditional methods.

Traditional glucose monitoring systems use enzymatic reactions with blood samples, but these methods are not shelf-stable, making them difficult to store and ship. The self-replicating properties of bacteria, however, offer a potential solution. Researchers at Binghamton University (New York, NY, USA) have developed a new paper-based biosensor system that uses Bacillus subtilis bacterial spores, which germinate in response to glucose in potassium-rich fluids like sweat. The power generated by the spores indicates the glucose level, and the system can withstand harsh environments, activating only when the right conditions are met. This novel approach could transform diabetes management by eliminating the need for painful finger-stick blood samples.

The research team had previously used paper as a platform to create detectors for lead ions in seawater. Their earlier work also includes integrating biobatteries into 3D-printed circuits, creating devices that generate moisture from the air, and designing self-powered mechanical bugs for collecting ocean data. In light of the current global energy crisis, using bacteria to generate power presents a promising, sustainable solution. Since the biosensor is paper-based and disposable, it is cost-effective and simple to use. After publishing their findings in the journal Microsystems & Nanoengineering, the researchers are now working on refining the detection process further.

“Everyone has a different potassium concentration in their sweat, and I don’t know how this concentration affects the glucose,” said Professor Seokheun “Sean” Choi, who adapted the knowledge of biobatteries gained in his Bioelectronics and Microsystems Lab over the past 15 years to build the paper-based biosensor system. “The sensitivity also is lower than conventional enzymatic biosensors. But from this work, we created a new sensing mechanism to detect glucose. No one has done that yet.”


New
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.